Ribozyme-Mediated Repair of Sickle
-Globin mRNAs in Erythrocyte Precursors
Ning Lan,
Richard P. Howrey,
Seong-Wook Lee,
*
Clayton A. Smith,
Bruce A. Sullenger
Sickle cell anemia is the most common heritable hematological
disease, yet no curative treatment exists for this disorder. Moreover,
the intricacies of globin gene expression have made the development of
treatments for hemoglobinopathies based on gene therapy difficult. An
alternative genetic approach to sickle cell therapy is based on RNA
repair. A trans-splicing group I ribozyme was used to alter mutant
-globin transcripts in erythrocyte precursors derived from
peripheral blood from individuals with sickle cell disease. Sickle
-globin transcripts were converted into messenger RNAs encoding the
anti-sickling protein
-globin. These results suggest that RNA repair
may become a useful approach in the treatment of genetic disorders.
N. Lan, S.-W. Lee, B. A. Sullenger, Center for Genetic and
Cellular Therapies, Departments of Surgery and Genetics, Duke
University Medical Center, Durham, NC 27710, USA.
R. P. Howery, Center for Genetic and Cellular Therapies,
Department of Pediatrics, Duke University Medical Center, Durham, NC
27710, USA.
C. A. Smith, Center for Genetic and Cellular Therapies, Department
of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
*
Current Address: Department of Molecular Biology, Dankook
University, Seoul, Korea.
To whom correspondence should be addressed: E-mail:
sulle001{at}mc.duke.edu